|
US6586617B1
(en)
*
|
1999-04-28 |
2003-07-01 |
Sumitomo Chemical Takeda Agro Company, Limited |
Sulfonamide derivatives
|
|
JP2001026506A
(ja)
*
|
1999-04-28 |
2001-01-30 |
Takeda Chem Ind Ltd |
スルホンアミド誘導体
|
|
US6503949B1
(en)
*
|
1999-05-17 |
2003-01-07 |
Noro Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
EP1335901B1
(en)
|
2000-10-17 |
2010-04-14 |
Merck Serono SA |
Pharmaceutically active sulfanilide derivatives
|
|
US6657070B2
(en)
|
2000-12-13 |
2003-12-02 |
Wyeth |
Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
|
|
ATE330950T1
(de)
|
2000-12-13 |
2006-07-15 |
Wyeth Corp |
Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion
|
|
GB0108592D0
(en)
|
2001-04-05 |
2001-05-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0108591D0
(en)
|
2001-04-05 |
2001-05-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US20040192673A1
(en)
*
|
2001-05-05 |
2004-09-30 |
Pascale Gaillard |
N-aroyl cyclic amine derivatives as orexin receptor antagonists
|
|
GB0115862D0
(en)
*
|
2001-06-28 |
2001-08-22 |
Smithkline Beecham Plc |
Compounds
|
|
JP2005504042A
(ja)
|
2001-08-03 |
2005-02-10 |
シェーリング コーポレイション |
γセクレターゼインヒビターのようなスルホンアミド誘導体
|
|
JP4418671B2
(ja)
*
|
2001-08-03 |
2010-02-17 |
シェーリング コーポレイション |
新規γセクレターゼインヒビター
|
|
GB0120347D0
(en)
|
2001-08-21 |
2001-10-17 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
HUP0500173A3
(en)
*
|
2001-12-20 |
2009-03-30 |
Bristol Myers Squibb Co |
Alpha-sulphonamido-acetamide derivatives as beta-amyloid inhibitors and pharmaceutical compositions containing them
|
|
PE20030701A1
(es)
|
2001-12-20 |
2003-08-21 |
Schering Corp |
Compuestos para el tratamiento de trastornos inflamatorios
|
|
CA2471943C
(en)
|
2001-12-27 |
2011-09-20 |
Daiichi Pharmaceutical Co., Ltd. |
.beta.-amyloid protein production-secretion inhibitors
|
|
DE10201392A1
(de)
*
|
2002-01-16 |
2003-07-31 |
Bayer Ag |
Phenylsulfoxide und-sulfone
|
|
PL374501A1
(en)
*
|
2002-06-11 |
2005-10-31 |
Wyeth |
Substituted phenylsulfonamide inhibitors of beta amyloid production
|
|
US6989399B2
(en)
|
2002-08-01 |
2006-01-24 |
Bristol-Myers Squibb Company |
Antiamyloid phenylsulfonamides: N-alkanol derivatives
|
|
GB0223038D0
(en)
|
2002-10-04 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
GB0223040D0
(en)
*
|
2002-10-04 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
GB0223039D0
(en)
|
2002-10-04 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
KR20050043988A
(ko)
|
2002-10-11 |
2005-05-11 |
액테리온 파마슈티칼 리미티드 |
설포닐아미노-아세트산 유도체 및 오렉신 수용체길항제로서 이들의 용도
|
|
US7521481B2
(en)
|
2003-02-27 |
2009-04-21 |
Mclaurin Joanne |
Methods of preventing, treating and diagnosing disorders of protein aggregation
|
|
WO2004080952A1
(de)
*
|
2003-03-10 |
2004-09-23 |
Bayer Healthcare Ag |
Phenylsulfonamid-derivate zur behandlung der alzheimerschen krankheit
|
|
MXPA05010368A
(es)
|
2003-03-31 |
2005-11-17 |
Wyeth Corp |
Sulfonamidas heterociclicas que contienen fluor- y trifluoroalquilo como inhibidores de la produccion beta amiloide y derivados de las mismas.
|
|
JP2006524248A
(ja)
*
|
2003-04-14 |
2006-10-26 |
ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー |
糖尿病の治療用のｎ−（（（（（１，３−チアゾール−２−イル）アミノ）カルボニル）フェニル）スルホニル）フェニルアラニン誘導体及び関連化合物
|
|
US7368457B2
(en)
|
2003-05-13 |
2008-05-06 |
Schering Corporation |
Bridged N-arylsulfonylpiperidines as gamma-secretase inhibitors
|
|
WO2004101538A1
(en)
|
2003-05-16 |
2004-11-25 |
Merck Sharp & Dohme Limited |
Cyclohexyl sulphones as gamma-secretase inhibitors
|
|
WO2004113277A2
(en)
*
|
2003-06-23 |
2004-12-29 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
|
KR20060066057A
(ko)
|
2003-06-30 |
2006-06-15 |
다이이찌 세이야꾸 가부시기가이샤 |
복소환 메틸 설폰 유도체
|
|
JP4448134B2
(ja)
|
2003-08-08 |
2010-04-07 |
シェーリング コーポレイション |
ベンズアミド置換基を有する環状アミンｂａｓｅ−１阻害剤
|
|
DE602004015476D1
(de)
|
2003-08-08 |
2008-09-11 |
Schering Corp |
Cyclische amine mit einem heterocyclischen substituenten als bace-1-inhibitoren
|
|
GB0323258D0
(en)
|
2003-10-04 |
2003-11-05 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
US7208488B2
(en)
|
2003-10-29 |
2007-04-24 |
Elan Pharmaceuticals, Inc. |
N-substituted benzene sulfonamides
|
|
ATE443701T1
(de)
|
2004-01-16 |
2009-10-15 |
Wyeth Corp |
Heterocyclische, ein azol enthaltende sulfonamidinhibitoren der beta-amyloid-produktion
|
|
CA2559047A1
(en)
*
|
2004-03-11 |
2005-09-29 |
Elan Pharmaceuticals, Inc. |
N-substituted benzene sulfonamides
|
|
CN1972914A
(zh)
|
2004-03-31 |
2007-05-30 |
詹森药业有限公司 |
作为组胺h3受体配合体的非咪唑杂环化合物
|
|
BRPI0511504A
(pt)
|
2004-05-26 |
2008-01-22 |
Eisai R&D Man Co Ltd |
composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides
|
|
AR050994A1
(es)
|
2004-06-30 |
2006-12-13 |
Schering Corp |
N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas, y composicion farmaceutica en base al compuesto
|
|
MX2007000760A
(es)
|
2004-07-22 |
2007-04-09 |
Schering Corp |
Amida sustituida inhibidora de b secretasa.
|
|
ATE458729T1
(de)
|
2004-10-26 |
2010-03-15 |
Eisai R&D Man Co Ltd |
Amorphe form einer zimtsäureamidverbindung
|
|
EP1805136A1
(en)
*
|
2004-10-28 |
2007-07-11 |
The Institutes for Pharmaceutical Discovery, LLC |
Substituted phenylalkanoic acids
|
|
WO2006078753A1
(en)
|
2005-01-18 |
2006-07-27 |
Elan Pharmaceuticals, Inc. |
N-substituted heterocyclic sulfonamides
|
|
EP1853594A2
(en)
|
2005-01-27 |
2007-11-14 |
Alma Mater Studiorum -Universita' di Bologna |
Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
|
|
BRPI0610532A2
(pt)
|
2005-04-08 |
2010-06-29 |
Daiichi Sankyo Co Ltd |
derivado de piridilmetilsulfona
|
|
MY144960A
(en)
|
2005-11-24 |
2011-11-30 |
Eisai R&D Man Co Ltd |
Morpholine type cinnamide compound
|
|
TWI370130B
(en)
|
2005-11-24 |
2012-08-11 |
Eisai R&D Man Co Ltd |
Two cyclic cinnamide compound
|
|
MX2008009414A
(es)
|
2006-01-20 |
2008-10-01 |
Schering Corp |
Arilsulfonas carbociclicas y heterociclicas como inhibidores de gamma secretasa.
|
|
JP2009533016A
(ja)
*
|
2006-02-06 |
2009-09-17 |
イーラン ファーマスーティカルズ、インコーポレイテッド |
プレセニリン１特異的阻害剤及びそれらの使用
|
|
WO2011053822A2
(en)
|
2009-11-01 |
2011-05-05 |
The Brigham And Women's Hospital, Inc. |
Notch inhibition in the treatment and prevention of obesity and metabolic syndrome
|
|
US9567396B2
(en)
|
2006-03-07 |
2017-02-14 |
Evonik Degussa Gmbh |
Notch inhibition in the prevention of vein graft failure
|
|
US8133857B2
(en)
|
2006-03-07 |
2012-03-13 |
The Brigham and Women's FHospital, Inc. |
NOTCH inhibition in the treatment of atherosclerosis
|
|
TWI378091B
(en)
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
|
EP2007717A1
(en)
|
2006-04-11 |
2008-12-31 |
Actelion Pharmaceuticals Ltd. |
Novel sulfonamide compounds
|
|
EA015555B1
(ru)
|
2006-05-30 |
2011-08-30 |
Янссен Фармацевтика Н.В. |
Замещенные пиридиламидные соединения в качестве модуляторов гистаминового h-рецептора
|
|
SA07280403B1
(ar)
|
2006-07-28 |
2010-12-01 |
إيساي أر أند دي منجمنت كو. ليمتد |
ملح رباعي لمركب سيناميد
|
|
TW200817319A
(en)
|
2006-08-10 |
2008-04-16 |
Astellas Pharma Inc |
Sulfonamide compound or salt thereof
|
|
US20110053995A1
(en)
*
|
2006-11-16 |
2011-03-03 |
The Regents Of The University Of California |
Benzenesulfonanilide compound inhibitors of urea transporters
|
|
CA2676715A1
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of ad and related conditions
|
|
CN101754960A
(zh)
|
2007-07-05 |
2010-06-23 |
先灵公司 |
四氢吡喃并色烯γ-分泌酶抑制剂
|
|
AU2008276492A1
(en)
|
2007-07-17 |
2009-01-22 |
Merck Sharp & Dohme Corp. |
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
|
|
US7935815B2
(en)
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
|
EP2181992B8
(en)
|
2007-08-31 |
2013-06-26 |
Eisai R&D Management Co., Ltd. |
Polycyclic compound
|
|
TW200920362A
(en)
|
2007-09-11 |
2009-05-16 |
Daiichi Sankyo Co Ltd |
Alkylsulfone derivatives
|
|
US8093276B2
(en)
|
2007-10-31 |
2012-01-10 |
Bristol-Myers Squibb Company |
Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
|
|
US8084477B2
(en)
*
|
2007-10-31 |
2011-12-27 |
Bristol-Myers Squibb Company |
Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
|
|
US8883776B2
(en)
|
2007-11-20 |
2014-11-11 |
Janssen Pharmaceutica N.V. |
Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine H3 receptor
|
|
KR101595238B1
(ko)
|
2007-12-21 |
2016-02-18 |
리간드 파마슈티칼스 인코포레이티드 |
선택적 안드로겐 수용체 조절제(ｓａｒｍ) 및 이의 용도
|
|
WO2009120783A1
(en)
*
|
2008-03-25 |
2009-10-01 |
The Johns Hopkins University |
High affinity inhibitors of hepatitis c virus ns3/4a protease
|
|
WO2009128057A2
(en)
|
2008-04-18 |
2009-10-22 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al |
Psycho-pharmaceuticals
|
|
JP2011523633A
(ja)
*
|
2008-05-08 |
2011-08-18 |
ブリストル−マイヤーズ スクイブ カンパニー |
２−アリールグリシンアミド誘導体
|
|
GB0812969D0
(en)
|
2008-07-15 |
2008-08-20 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
TW201020247A
(en)
*
|
2008-11-06 |
2010-06-01 |
Gruenenthal Gmbh |
Substituierte disulfonamide
|
|
US8044077B2
(en)
|
2009-03-19 |
2011-10-25 |
Bristol-Myers Squibb Company |
Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production
|
|
US7977362B2
(en)
|
2009-03-20 |
2011-07-12 |
Bristol-Myers Squibb Company |
Alpha-(N-benzenesulfonamido)cycloalkyl derivatives
|
|
US8252821B2
(en)
|
2009-04-14 |
2012-08-28 |
Bristol-Myers Squibb Company |
Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound
|
|
NZ596137A
(en)
|
2009-05-14 |
2013-08-30 |
Janssen Pharmaceutica Nv |
Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
|
|
CN103193691B
(zh)
*
|
2012-01-06 |
2017-08-25 |
中国科学院上海药物研究所 |
磺胺类化合物、药物组合物及其制法和应用
|
|
JP6134338B2
(ja)
*
|
2012-02-29 |
2017-05-24 |
バルーク エス．ブルームバーグ インスティテュート |
Ｂ型肝炎ウイルス共有結合閉環状ｄｎａ形成の阻害剤およびそれらの使用方法
|
|
US9688715B2
(en)
|
2012-06-22 |
2017-06-27 |
Temple University—Of the Commonwealth System of Higher Education |
Synthetic pGpG analogs, methods of preparation and methods of use
|
|
KR20150061647A
(ko)
*
|
2012-09-27 |
2015-06-04 |
에프. 호프만-라 로슈 아게 |
치환된 설폰아미드 화합물
|
|
CA2908695A1
(en)
|
2013-04-05 |
2014-10-09 |
Salk Institute For Biological Studies |
Ppar agonists
|
|
US10441567B2
(en)
|
2014-01-17 |
2019-10-15 |
Ligand Pharmaceuticals Incorporated |
Methods and compositions for modulating hormone levels
|
|
EP2932966A1
(en)
|
2014-04-16 |
2015-10-21 |
Novartis AG |
Gamma secretase inhibitors for treating respiratory diseases
|
|
CN104151277A
(zh)
*
|
2014-06-30 |
2014-11-19 |
北京万全德众医药生物技术有限公司 |
盐酸决奈达隆一种氧化杂质的制备方法
|
|
WO2016057322A1
(en)
|
2014-10-08 |
2016-04-14 |
Salk Institute For Biological Studies |
Ppar agonists and methods of use thereof
|
|
WO2016090317A1
(en)
*
|
2014-12-05 |
2016-06-09 |
Aquinnah Pharmaceuticals, Inc. |
Sulfonamide derivatives, compositions and methods of use in the treatment of neurodegenerative diseases
|
|
CN106466313A
(zh)
*
|
2015-08-18 |
2017-03-01 |
中国科学院上海药物研究所 |
一类磺酰胺基取代的酰胺类衍生物在制备用于治疗阿尔茨海默病的药物中的用途
|
|
MA52648A
(fr)
|
2015-10-07 |
2021-10-13 |
Mitobridge Inc |
Agonistes de ppar, composés, compositions pharmaceutiques et leurs procédés d'utilisation
|
|
JP6925367B2
(ja)
|
2016-04-13 |
2021-08-25 |
ミトブリッジ，インコーポレーテッド |
Ｐｐａｒアゴニスト、化合物、医薬組成物、及びその使用方法
|
|
TWI754702B
(zh)
*
|
2016-12-28 |
2022-02-11 |
德商Ｕｃｂ製藥有限公司 |
（氮雜）吲哚－和苯並呋喃－３－磺醯胺類
|
|
JP7395480B2
(ja)
|
2018-01-10 |
2023-12-11 |
クラ セラピューティクス， エルエルシー |
フェニルスルホンアミドを含む薬学的組成物、及びそれらの治療的適用
|
|
US12485126B2
(en)
|
2018-07-19 |
2025-12-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Combination for treating cancer
|
|
CA3133929A1
(en)
|
2019-04-19 |
2020-10-22 |
Lin Zhi |
Crystalline forms and methods of producing crystalline forms of a compound
|
|
US20220274921A1
(en)
*
|
2019-07-11 |
2022-09-01 |
Cura Therapeutics, Llc |
Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
|
CN112457687B
(zh)
*
|
2019-09-06 |
2022-10-25 |
台湾永光化学工业股份有限公司 |
新颖反应性染料
|
|
US20230416830A1
(en)
|
2020-11-16 |
2023-12-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for predicting and treating uveal melanoma
|